Many women feel that their health concerns are not being adequately addressed. Fortunately, there have been some big changes when it comes to healthcare with entrepreneurs like Marc Beer working to treat and diagnose health problems that impact women. He has led companies in the healthcare industrybefore, but his most recent project is Renovia. Renovia focuses on the development of products for women with pelvic floor disorder. The company is based out of the Boston area and was founded in 2016 by Marc Beer who is their Chairman and Chief Executive Officer.
During their first round of funding, Renovia was able to raise an impressive amount of capital under the leadership of Marc Beer. With this money, they were able to get one of their products approved by the Food and Drug Administration already with several more in different levels of the development process. The second round of funding raised total funding for $42 million. Encouraged by the progress made by the company already, some of the investors that had been part of the company’s early funding returned for the second round.
Many of the Renovia investors are leaders in the healthcare investment industry. Marc Beer is excited about having their support and believes that they will help him change the lives of millions of women with pelvic floor disorder. The disorder is uncomfortable and in some cases, it can even be painful. It’s a disorder that Marc Beer believes has a lot of room for progress in order to improve the quality of life for these women suffering from pelvic floor disorder around the world. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html
The devices produced by Renovia have sensors embedded into them that use proprietary technology that is truly state of the art. This will help researchers and physicians know more about the condition and also allow patients to track their data using an app. Marc Beer and Renovia will be using this funding to create a newer version of their device that had previously been approved by the Food and Drug Administration along with other products that are targeted towards the treatment of pelvic floor disorder along with diagnostic devices.
With a decade and a half of experience under his belt in different health care industries, Marc Beer is well known on Wall Street for his work. He has worked with the diagnostic, pharmaceutical, biotechnology sectors during his career and continues to do so to this day. In addition to his responsibilities at Renovia, he is also involved with 2 other companies as well. Marc Beer serves as a Chairman for both Good Start Genetics and Minerva Biosciences since 2010 and 2013.